HSPA1A and cancer: Although HSPA1A-related small molecules drugs have been developed [70] to target similar signaling path, such drugs may be toxic not only to cancer cells, but also to normal cells due to their inhibitory effects on normal cellular function like protein folding, autophagy, and lysosomal function.